Search results
Showing 1171 to 1185 of 1198 results for pain
NICE calls for further research into the treatment of chronic lipoedema
NICE has today issued interventional procedures guidance on the use of liposuction for the treatment of chronic lipoedema.
NICE does not recommend elusulfase alfa for NHS use following evaluation of new evidence
NICE has today (12 November 2021) published draft guidance for public consultation which does not recommend elosulfase alfa (also called Vimizin and made by BioMarin) for the treatment of mucopolysaccharidosis type 4A (also known as MPS 4A and Morquio A syndrome).
Healthier lifestyle can help to ease osteoarthritis symptoms says NICE
Exercise has an important role to play in helping people living with osteoarthritis NICE says in draft updated guidelines published today (29th April 2022) on the care and management of people with the condition.
Antibiotics should not be used to treat the majority of sinus infections, NICE says
NICE is advising healthcare professionals to tell their patients that a sinus infection will likely clear-up without antibiotics and that there is little evidence oral decongestants will help to relieve their symptoms.
A number of commonly used drug treatments for chronic primary pain have little or no evidence that they work and shouldn’t be prescribed, NICE has said in its draft clinical guideline published today (3 August 2020) on the assessment and management of chronic pain in over 16s.
Diagnose and treat Lyme disease if bull's eye rash is present, says NICE
People presenting erythema migrans, the characteristic skin rash associated with Lyme disease, can be diagnosed and treated without the need for blood tests, NICE has said in a final quality standard published today.
People with chronic primary pain should be offered a range of treatments to help them manage their condition, NICE has said in its guideline on the assessment and management of chronic pain published today (7 April).
NICE recommends several treatment options to help thousands with moderate rheumatoid arthritis
Around 25,000 people with moderate rheumatoid arthritis that has not responded to conventional therapies are set to benefit from the recommendations announced today
NICE, the Scottish Intercollegiate Guidelines Network (SIGN) and the Royal College of General Practitioners (RCGP) have today (30 October 2020) given more details about the forthcoming guideline on post-COVID syndrome.
People with a rare condition that steadily worsens often leaving them dependent on a wheelchair and with shortened life expectancy, can now benefit from the first treatment to slow its progression.
NICE recommends first treatment in two decades for sickle cell disease
Hundreds of people will be eligible for a new treatment for sickle cell disease following draft guidance published today (5 October).
NICE has published 2 new rapid COVID-19 guidelines on the care of patients with suspected and confirmed COVID-19.
NICE is calling for early identification of asymptomatic and symptomatic peripheral arterial disease to help improve the care of patients with the condition.
NICE recommends a weekly injection for treating growth failure in children
This recommendation comes from a pilot to develop simpler, faster evaluations for the appraisal of some treatments.
NICE opens consultation on draft pelvic floor dysfunction guideline recommendations
NICE has today (28 June 2021) published its draft guideline on the prevention and non-surgical management of pelvic floor dysfunction and is seeking stakeholder comments on the draft recommendations.